Sabyasachi Choudhuri

Mr. Sabyasachi Choudhuri

Maulana Abul Kalam Azad University of Technology, West Bengal, Kolkata, India
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2022 in Encyclopedia
Verified
Journal Article
Open access
PDF file
CHChowdhury Mobaswar Hossain
Chowdhury Mobaswar Hossain
Lisa Kathleen RyanLisa Kathleen Ryan
Lisa Kathleen Ryan
GMGera Meeta
Gera Meeta
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
NLNazmun Lyle
Nazmun Lyle
Gill DiamondGill Diamond
Gill Diamond
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth of fungi (termed fungistatic) or by killing the fungal cells (termed fungicidal). Antibiotics also prevent bacterial infections through either bacteriostatic or bactericidal mechanisms. These microorganisms successfully develop resistance against conventional drugs that are designed to kill or stop them from multiplying. When a fungus no longer responds to antifungal drug treatments and continues to grow, this is known as antifungal drug resistance. Bacteria have an amazing capacity to become resistant to antibiotic action as well, and the effectiveness of the scarce antifungal arsenal is jeopardised by this antibiotic resistance, which poses a severe threat to public health.

10 May 2022 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
NPNabanita Panja
Nabanita Panja
SMSumana Maji
Sumana Maji
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
KAKazi Asraf Ali
Kazi Asraf Ali
CHChowdhury Mobaswar Hossain
Chowdhury Mobaswar Hossain

29 September 2023 in Bioprinting
Verified
Journal Article
Closed access
KAKazi Asraf Ali
Kazi Asraf Ali
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
SMSk Mohin
Sk Mohin
SGSusmita Goswami
Susmita Goswami

13 May 2025
Verified
Book Chapter
Closed access
KAKazi Asraf Ali
Kazi Asraf Ali
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
SRSanjit Kr. Roy
Sanjit Kr. Roy
KRKhandekar Hussan Reza
Khandekar Hussan Reza
DMDipika Mandal
Dipika Mandal
CHChowdhury Mobaswar Hossain
Chowdhury Mobaswar Hossain
Integrating artificial intelligence (AI) with nanotechnology has revolutionized immunological research by enabling the precise design, optimization, and functionalization of nanoparticles. AI-generated nanoparticles (AIGNPs) exhibit enhanced capabilities in vaccine development, cancer immunotherapy, and autoimmune disease treatment through improved antigen delivery, targeted drug release, and immune modulation. AI-powered models help researchers quickly analyze how nanoparticles behave, interact with immune cells, and determine their compatibility with the body. This speeds up the development of new treatments. But there are still a lot of obstacles. Obstacles still include strict legal requirements, moral dilemmas, and the requirement for extensive experimental support. AI-generated nanoparticles have infinite therapeutic potential once these obstacles are removed. Resolving these issues could result in more precise and personalized cancer immunotherapy, which would revolutionize patient care.

5 June 2020 in International Journal of Science and Research (IJSR)
Verified
Journal Article
Closed access
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
SDSoumya Deb
Soumya Deb

7 March 2023
Verified
Book Chapter
Closed access
PDF file
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
JPJyotirmoy Panda
Jyotirmoy Panda